AIMS Molecular Science

Scope & Guideline

Fostering Collaboration in Cutting-edge Molecular Research

Introduction

Welcome to the AIMS Molecular Science information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of AIMS Molecular Science, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2372-0301
PublisherAMER INST MATHEMATICAL SCIENCES-AIMS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationAIMS MOL SCI / AIMS Mol. Sci.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 2604, SPRINGFIELD, MO 65801-2604, UNITED STATES

Aims and Scopes

AIMS Molecular Science is dedicated to advancing our understanding of molecular and cellular processes in health, disease, and environmental interactions. The journal emphasizes multidisciplinary research approaches that integrate molecular biology, biochemistry, pharmacology, and biotechnology.
  1. Molecular Genetics and Genomics:
    Research in this area focuses on genetic factors influencing health and disease, including studies on gene variations and their implications in conditions like cleft lip palate and various cancers.
  2. Phytochemistry and Natural Products:
    The journal publishes studies on the extraction, characterization, and bioactivity of phytochemicals, highlighting their potential in therapeutic applications and anti-inflammatory properties.
  3. Aquatic and Environmental Health:
    Research related to aquatic species health, including the characterization of pathogenic bacteria and their effects on aquaculture, is a significant focus.
  4. Computational Biology and Bioinformatics:
    The use of computational methods, including molecular docking and QSAR studies, to predict the interactions and therapeutic potentials of various compounds is a recurring theme.
  5. Neurobiology and Neurodegenerative Diseases:
    The journal covers molecular mechanisms underlying neurodegenerative diseases, exploring genetic and environmental factors that contribute to conditions such as Alzheimer’s and bipolar disorder.
  6. Immunology and Inflammation:
    Research on the immune response, including the role of extracellular traps and inflammatory markers in various diseases, is a critical area of interest.
  7. Cancer Research and Therapeutics:
    The journal includes studies on cancer biology, therapeutic strategies, and the role of natural products in cancer treatment.
AIMS Molecular Science reflects the evolving landscape of molecular research, with several emerging themes gaining traction in recent years. This section identifies these trending areas of focus.
  1. Personalized Medicine and Nutrigenomics:
    There is an increasing emphasis on personalized approaches to health, particularly in the context of nutrigenetics, which explores how genetic variations influence individual responses to dietary interventions.
  2. COVID-19 Research:
    Research related to COVID-19, encompassing viral mechanisms and therapeutic strategies, has surged, reflecting the global health crisis and the need for innovative treatments.
  3. Bioactive Compounds and Their Applications:
    The exploration of bioactive compounds from plants, particularly their extraction methods and therapeutic potentials, is trending, highlighting the journal's commitment to natural product research.
  4. Neurobiology and Mental Health:
    Research on the molecular basis of neurodegenerative diseases and mental health disorders is becoming increasingly prominent, with studies focusing on genetic influences and therapeutic potentials.
  5. Environmental and Aquatic Health:
    The focus on environmental impacts on health, particularly in aquatic systems and the management of aquatic animal diseases, is on the rise, reflecting growing concerns over biodiversity and ecosystem health.

Declining or Waning

While AIMS Molecular Science has a robust and diverse range of research areas, certain themes have seen a reduction in focus over recent publications. This section highlights those declining themes.
  1. Traditional Pharmacology:
    There appears to be a waning interest in traditional pharmacological approaches, with more emphasis shifting towards molecular and genetic studies as well as integrative medicinal approaches.
  2. Basic Microbiology:
    Research focusing solely on basic microbiological studies without a molecular or genomic angle seems to be decreasing, as the journal favors studies that combine microbiology with molecular insights.
  3. Epidemiological Studies:
    While still relevant, straightforward epidemiological studies are less frequent, with an increasing trend towards studies that incorporate genetic or molecular data to provide a deeper understanding of disease mechanisms.

Similar Journals

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Illuminating the Dynamics of Life at the Molecular Level
Publisher: TAYLOR & FRANCIS INCISSN: 0739-1102Frequency: 18 issues/year

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, published by TAYLOR & FRANCIS INC, serves as a pivotal platform for the dissemination of original research in the fields of biochemistry, molecular biology, and structural biology. With an ISSN of 0739-1102 and an E-ISSN of 1538-0254, this esteemed journal has garnered attention for its rigorous peer-review process and commitment to high-quality scientific inquiry since its inception in 1981. Ranking in the Q2 quartile for miscellaneous medicine and the Q3 quartile for both molecular and structural biology, it consistently demonstrates a significant impact within its specialties, evidenced by a high Scopus ranking. Researchers, professionals, and students are encouraged to engage with cutting-edge studies addressing the complex interactions and dynamics of biomolecules, making this journal a vital resource for advancing knowledge in the biological sciences. Although it does not offer open access options, its valuable contributions are vital for the ongoing discourse within the scientific community.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Exploring the Foundations of Health and Disease
Publisher: ELSEVIERISSN: 0925-4439Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

ACTA BIOCHIMICA POLONICA

Advancing Insights in Biochemistry and Molecular Biology
Publisher: ACTA BIOCHIMICA POLONICAISSN: 0001-527XFrequency: 4 issues/year

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Unveiling the Secrets of Life through Cutting-edge Science.
Publisher: SCIENCE PRESSISSN: 1672-9145Frequency: 12 issues/year

ACTA BIOCHIMICA ET BIOPHYSICA SINICA, an esteemed journal published by SCIENCE PRESS, is a leading platform in the fields of biochemistry, biophysics, and molecular biology. Based in the United Kingdom, this journal has consistently ranked in the Q2 category for Biochemistry, Biophysics, and Medicine (miscellaneous) in 2023, showcasing its commitment to high-quality research and innovation in life sciences. With a convergence period extending from 1996 to 2024, it features critical insights into biochemical and biophysical processes that underlie biological phenomena. Researchers and professionals seeking to stay at the forefront of discoveries will find its articles to be both informative and transformative. Although not an open-access journal, ACTA BIOCHIMICA ET BIOPHYSICA SINICA aims to advance knowledge and foster collaboration among scientists worldwide, emphasizing its role in the dynamic landscape of biomedical research.

Advanced Biology

Fostering Collaboration for Scientific Breakthroughs
Publisher: WILEY-V C H VERLAG GMBHISSN: 2701-0198Frequency: 12 issues/year

Advanced Biology, published by WILEY-V C H VERLAG GMBH, serves as a premier platform where innovative research and scientific breakthroughs in the fields of biochemistry, genetics, and molecular biology converge. Established in 2021, this journal has rapidly ascended to prominence, securing Q1 rankings in its primary categories, including general biochemistry and biomedical engineering, and a solid Q2 ranking in biomaterials. With an ISSN of 2701-0198 and an emphasis on open access, Advanced Biology ensures that rigorous peer-reviewed research is accessible to a global audience, enhancing visibility and fostering collaboration among researchers, professionals, and students alike. By 2024, it aims to continually elevate scientific understanding and innovation, catering to the growing interdisciplinary nature of these critical fields. With Scopus rankings placing it amongst the top quartiles in its disciplines, Advanced Biology is poised to make significant contributions to the future of life sciences.

YEAST

Transforming yeast research into impactful biotechnological solutions.
Publisher: WILEYISSN: 0749-503XFrequency: 12 issues/year

YEAST is a renowned peer-reviewed journal published by WILEY, dedicated to advancing the understanding of yeast biology and its applications in various scientific fields. Since its inception in 1985, YEAST has significantly contributed to the disciplines of microbiology, biotechnology, biochemistry, and genetics, achieving respectable rankings within its categories, including Q2 status in Applied Microbiology and Biotechnology and Q2 in Biotechnology as of 2023. With an emphasis on high-quality research, it explores diverse aspects of yeast organisms, from their cellular mechanisms to biotechnological applications. Although it does not currently offer an open-access option, the journal provides valuable insights and findings that are applicable to both academia and industry, making it an essential resource for researchers, professionals, and students interested in the functional and applied dimensions of yeast. With its editorial rigor and commitment to quality, YEAST continues to be a vital platform for disseminating innovative research that shapes future biotechnological advancements.

Molecular Biology Research Communications

Cultivating collaboration in the evolving landscape of molecular research.
Publisher: SHIRAZ UNIVISSN: 2322-181XFrequency: 4 issues/year

Molecular Biology Research Communications is a distinguished academic journal published by Shiraz University, focusing on the critical and rapidly evolving fields of biochemistry and molecular biology. With an ISSN of 2322-181X and an E-ISSN of 2345-2005, this journal serves as an essential platform for researchers, professionals, and students to disseminate significant findings that contribute to the advancement of knowledge in these disciplines. The journal, operating from Shiraz, Iran, is notable for its contributions from both local and international scholars, offering invaluable insights and fostering scientific collaboration. Although currently indexed in the Q4 quartile across its categories, the journal aims to enhance its impact and visibility in the field as it converges years of research from 2017 to 2024. While the open access option is not available, the journal's commitment to high-quality peer-reviewed research provides a respected avenue for publication.

Frontiers in Molecular Biosciences

Transforming Research into Understanding in Molecular Sciences
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Molecular Biosciences is an esteemed open-access journal published by FRONTIERS MEDIA SA, based in Switzerland. Since its inception in 2014, the journal has made significant strides in the fields of biochemistry, genetics, and molecular biology, cementing its reputation with a solid position in the Q1 quartile for both Biochemistry and Genetics and Molecular Biology (miscellaneous) categories as of 2023. With a remarkable Scopus rank of #14/103 in the combined categories, it offers an essential platform for the dissemination of high-quality research that shapes the understanding of molecular processes and their implications in health and disease. The journal’s commitment to open access facilitates the broadest possible reach for groundbreaking discoveries, serving as a vital resource for researchers, professionals, and students alike. Located at AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, this journal continues to foster innovative discussions and advancements in molecular biosciences, paving the way for new insights and collaborations in the scientific community.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Elevating Research in Receptor Dynamics
Publisher: TAYLOR & FRANCIS LTDISSN: 1079-9893Frequency: 6 issues/year

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

Open Biology

Fueling scientific exploration with unrestricted access.
Publisher: ROYAL SOCISSN: Frequency: 12 issues/year

Open Biology is a prestigious, interdisciplinary journal published by the Royal Society that has been paving the way in the fields of Biochemistry, Genetics and Molecular Biology, Immunology, and Neuroscience since its inception in 2011. Catering to a global audience of researchers, professionals, and students, Open Biology operates under an open access model, facilitating the unrestricted dissemination of high-quality research findings. With a current impact factor that positions its categories in the top quartile (Q1) and impressive Scopus rankings—evidencing its influence and reach—this journal serves as a vital platform for innovators and scientific inquiries aimed at advancing our understanding of life sciences. The journal's commitment to publishing cutting-edge research makes it an essential resource for those at the forefront of scientific exploration.